Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Frailty 3Neoplasms 2Stomach Neoplasms 1Recurrence 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Colorectal Neoplasms 1Cognitive Dysfunction 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Neuropsychological Tests 2Vitamin D 1Standard of Care 1Silymarin 1Physical Conditioning, Human 1Patient Reported Outcome Measures 1Mindfulness 1Geriatric Assessment 1Exergaming 1Counseling 1Coping Skills 1Cognitive Training 1Blood Specimen Collection 1Aspirin 1Ashwagandha 1Anticonvulsants 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cognitive Dysfunction × Geriatric Assessment × Clear all
NCT06022666 2024-08-23

PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.

Nova Scotia Health Authority

Phase NA Unknown
150 enrolled

Frailty, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡